Featured
Early Kidney Disease Diagnosis Rates Stagnant
Trial Briefs Sep 11, 2026
Drug Approvals Sep 10, 2026
Vaccine News Sep 9, 2026
Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a...
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with...
Botox migraine therapy is gaining attention as it shows relief for migraine and spasticity, providing...
Read our latest Drug Approvals articles.
Vonoprazan significantly reduces nighttime reflux symptoms in patients with NERD, offering a promising new treatment...
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial...
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify...
Early kidney disease diagnosis rates remain stagnant despite increased screening, highlighting challenges in healthcare detection.
Early kidney disease diagnosis rates remain stagnant despite increased screening, highlighting challenges in healthcare detection.
Vonoprazan significantly reduces nighttime reflux symptoms in patients with NERD, offering a promising new treatment option for better sleep.
New diagnostic guidelines for suspected epilepsy focus on ruling out seizures and classifying focal or generalized types—experts emphasize patient history...
Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a study at the Epilepsy Congress.
New study finds valbenazine significantly improves quality of life for adults with tardive dyskinesia.
Discover how dual therapy is reshaping spinal muscular atrophy treatment as experts debate combining treatments to improve SMA patient outcomes.
The American Academy of Neurology and American Headache Society released an updated migraine prevention guideline for adults, replacing the 2012.
Study reveals combined risk factors significantly increase late-onset Parkinson disease risk, with multiple exposures showing synergistic effects beyond individ
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial period.
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with updated recommendations.